serinatherapeutics.com (SER): Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Logo grafis Serina (SER)

The development of Serina Therapeutics, Inc. (SER) relies on the success of clinical trials and patent protection. The estimated EPS growth for the coming year shows a peak, after which the 29.10 level captures the current state. The company's strong pricing power is based on low-toxicity molecule delivery to the brain. The business is currently scaling its Parkinson's disease therapy, ensuring stable drug efficacy.

Serina Therapeutics Inc (SER): Prakiraan wutah bathi resik saben saham ing taun ngarep saka 28.03.2024 nganti 18.11.2026

Rincian metrik lan analitis perusahaan Serina Therapeutics Inc (SER)

Analisis wiwitan perusahaan:Serina Therapeutics Inc, SER
Produk merek Serina Therapeutics

For Serina Therapeutics, Inc. (SER), the potential for royalty payments from the POZ platform directly determines future profitability, which is reflected in the consensus earnings forecast for the coming year. This indicator measures the percentage change in expected earnings per share, capturing real-time revisions to analyst models. By analyzing the historical trend of the n+1 earnings forecast, an investor assesses the stability of fundamental expectations, where any sharp reversal signals risks of failing to meet business targets.

Pesaing Serina Therapeutics, Inc.

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Jazz Pharmaceuticals|CYTK: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep PTC Bio (PTCT)|SRRK - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Centessa Pharmaceuticals PLC CNTA|Dyne Pharma (DYN) - Prakiraan wutah bathi resik saben saham ing taun ngarep|EWTX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Rapport Therapeutics, Inc.|ALMS: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Kempharm ZVRA|Prakiraan wutah bathi saben saham kanggo taun ngarep CTNM|Prakiraan wutah bathi resik saben saham ing taun ngarep Larimar Corp LRMR|Prakiraan wutah bathi kanggo taun ngarep CAPR|TRDA - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PTHS (Channel Therapeutics Corp)|MediciNova Corp (MNOV) - Prakiraan wutah bathi resik saben saham ing taun ngarep|BTAI - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|promisneurosciences.com (PMN) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Apimeds (APUS) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep AEON|Prakiraan wutah bathi resik saben saham kanggo taun ngarep NLS Pharma|Prakiraan wutah bathi resik saben saham ing taun ngarep bionomics.com.au BNOX|Prakiraan wutah bathi kanggo taun ngarep HUGE|RETA (Reata Pharma) - Dinamika bathi saben saham sing diarepake ing taun ngarep